Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Conditions: Irritable Bowel Syndrome With Constipation; Functional Constipation Interventions: Drug: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers); Drug: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers): Sponsors: Allergan; Ironwood Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials